ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Physician Assistant

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,479Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 103

$503K Total Retail Price of All Prescriptions

Rank: 2 out of 103

396 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
22% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Montana
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 396 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

13% of this provider’s 396 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 8,537 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Montana
LEVOTHYROXINE SODIUM 574 502 1 1
LISINOPRIL 451 381 2 2
OMEPRAZOLE 337 303 3 5
SIMVASTATIN 333 298 4 3
HYDROCODONE-ACETAMINOPHEN 289 238 S3 5 4
WARFARIN SODIUM 286 272 6 10
FUROSEMIDE 263 236 7 6
METFORMIN HCL 226 192 8 9
METOPROLOL SUCCINATE 218 185 9 12
HYDROCHLOROTHIAZIDE 212 172 10 8
AMLODIPINE BESYLATE 181 181 11 7
ATENOLOL 159 139 12 20
DIGOXIN 154 145 13 29
METOPROLOL TARTRATE 134 125 14 11
SPIRONOLACTONE 124 101 15 51
PRAVASTATIN SODIUM 120 118 16 25
LOSARTAN POTASSIUM 117 115 17 14
LISINOPRIL-HYDROCHLOROTHIAZIDE 116 94 18 30
POTASSIUM CHLORIDE 113 110 19 13
PREDNISONE 109 98 20 22
NEXIUM 105 65 21 58
GABAPENTIN 104 75 22 18
ALLOPURINOL 103 91 23 35
ZOLPIDEM TARTRATE 98 68 24 23
DIOVAN 95 83 25 53
SYNTHROID 94 75 26 43
GEMFIBROZIL 94 94 26 62
GLIMEPIRIDE 92 87 28 82
ATORVASTATIN CALCIUM 91 83 29 33
CITALOPRAM HBR 90 61 30 15
ESTRADIOL 88 53 R 31 84
OXYCODONE HCL 85 53 S2 32 21
SERTRALINE HCL 82 68 33 28
CARVEDILOL 79 47 34 16
CRESTOR 77 74 35 39
OXYCONTIN 76 37 S2 36 36
CIPROFLOXACIN HCL 74 67 37 34
OXYBUTYNIN CHLORIDE 68 62 38 44
LOSARTAN-HYDROCHLOROTHIAZIDE 67 55 39 72
CELEBREX 66 46 40 101
PREMARIN 63 39 R 41 56
TRAZODONE HCL 61 29 42 69
TAMSULOSIN HCL 61 61 42 19
TRIAMTERENE-HCTZ 60 60 44 108
EVISTA 60 59 44 108
TORSEMIDE 58 48 46 112
AZITHROMYCIN 55 42 47 17
TRAMADOL HCL 54 42 48 45
CYMBALTA 53 20 49 47
ADVAIR DISKUS 50 49 50 24
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.